{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:58:46Z","timestamp":1775685526309,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasite Epidemiology and Control"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.parepi.2026.e00477","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:01:42Z","timestamp":1768838502000},"page":"e00477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Residual antimalarial drug concentrations before treatment in malaria patients in Asia and Africa: A systematic review and meta-analysis depicting its implication for drug pressure"],"prefix":"10.1016","volume":"32","author":[{"given":"Karol J.","family":"Marwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Zinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein R.","family":"Mnkungwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritah","family":"Mutagonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Kapesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard O.","family":"Mwaiswelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Mmbando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.A.","family":"Lusingu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erasmus","family":"Kamugisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parepi.2026.e00477_bib168","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12936-020-03553-6","article-title":"Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria","volume":"20","author":"Anyorigiya","year":"2021","journal-title":"Malaria J."},{"key":"10.1016\/j.parepi.2026.e00477_bb0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parepi.2026.e00477_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/clpt.2010.297","article-title":"Population pharmacokinetics of sulfadoxine and pyrimethamine in Malawian children with malaria","volume":"89","author":"Bell","year":"2011","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"key":"10.1016\/j.parepi.2026.e00477_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"Booth","year":"2012","journal-title":"Syst. Rev."},{"key":"10.1016\/j.parepi.2026.e00477_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1473-3099(22)00822-2","article-title":"WHO antimalarial strategy for Africa","volume":"23","author":"Burki","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00477_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-9-43","article-title":"Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria","volume":"9","author":"Congpuong","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.parepi.2026.e00477_bb0030","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/infdis\/jit078","article-title":"Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants","volume":"207","author":"Creek","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00477_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/qjmed\/hci121","article-title":"Pre-treatment with chloroquine and parasite chloroquine resistance in Ghanaian children with severe malaria","volume":"98","author":"Evans","year":"2005","journal-title":"Qjm"},{"key":"10.1016\/j.parepi.2026.e00477_bib167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202745","article-title":"Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania","volume":"13","author":"Gallay","year":"2018","journal-title":"PloS one"},{"key":"10.1016\/j.parepi.2026.e00477_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1475-2875-7-124","article-title":"Antimalarial drug use in general populations of tropical Africa","volume":"7","author":"Gardella","year":"2008","journal-title":"Malar. J."},{"key":"10.1016\/j.parepi.2026.e00477_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pt.2005.12.011","article-title":"Tolerance is the key to understanding antimalarial drug resistance","volume":"22","author":"Hastings","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.parepi.2026.e00477_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008184","article-title":"Residual antimalarials in malaria patients from Tanzania\u2013implications on drug efficacy assessment and spread of parasite resistance","volume":"4","author":"Hodel","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.parepi.2026.e00477_bb0055","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1086\/655779","article-title":"Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure","volume":"202","author":"Hodel","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00477_bb0060","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","article-title":"Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance","volume":"24","author":"Ishengoma","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00477_bb0065","unstructured":"Kaitholia K, Kumar A, Bhatnagar S, Rana R, Shankar H, Bhatt RM, Anvikar AR, Valecha N and Mishra N n.d. Residual Antimalarial Levels in Plasmodium Falciparum Malaria Patients from Selected Sites in India: An indication of Drug Pressure."},{"key":"10.1016\/j.parepi.2026.e00477_bb0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Malaria","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.parepi.2026.e00477_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijid.2022.08.020","article-title":"Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania","volume":"123","author":"Marwa","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.parepi.2026.e00477_bb0080","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1179\/136485905X75395","article-title":"Chloroquine-treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86","volume":"99","author":"Mockenhaupt","year":"2005","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.parepi.2026.e00477_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.parepi.2026.e00477_bb0090","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1128\/AAC.02595-14","article-title":"Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated plasmodium falciparum malaria in Tanzania","volume":"58","author":"Mosha","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parepi.2026.e00477_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1914-9","article-title":"Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women","volume":"16","author":"Mutagonda","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.parepi.2026.e00477_bb0100","series-title":"WHO Guidelines for Malaria, 14 March 2023","author":"Organization WH","year":"2023"},{"key":"10.1016\/j.parepi.2026.e00477_bb0105","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"bmj"},{"key":"10.1016\/j.parepi.2026.e00477_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-7-229","article-title":"Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies","volume":"7","author":"Pongtavornpinyo","year":"2008","journal-title":"Malar. J."},{"key":"10.1016\/j.parepi.2026.e00477_bib166","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/tropej\/fmh104","article-title":"Pretreatment blood concentrations of chloroquine in patients with malaria infection: relation to response to treatment","volume":"51","author":"Quashie","year":"2005","journal-title":"J. Trop. Pediatrics"},{"key":"10.1016\/j.parepi.2026.e00477_bb0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","article-title":"Current and emerging strategies to combat antimalarial resistance","volume":"20","author":"Rasmussen","year":"2022","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.parepi.2026.e00477_bb0120","first-page":"157","article-title":"Publication bias and funnel plot","author":"Sadeghi","year":"2025","journal-title":"Syst. Rev. Meta-Anal."},{"key":"10.1016\/j.parepi.2026.e00477_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4040","article-title":"Meta-analyses: heterogeneity and subgroup analysis","volume":"346","author":"Sedgwick","year":"2013","journal-title":"Bmj"},{"key":"10.1016\/j.parepi.2026.e00477_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/9781118493816.ch14","article-title":"Antimalarial drug resistance","author":"Shah","year":"2016","journal-title":"Adv. Malaria Res."},{"key":"10.1016\/j.parepi.2026.e00477_bb0135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0035-9203(95)90436-0","article-title":"A simple method for assessing quinine pre-treatment in acute malaria","volume":"89","author":"Silamut","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.parepi.2026.e00477_bb0140","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.00903-07","article-title":"Pharmacokinetic determinants of the window of selection for antimalarial drug resistance","volume":"52","author":"Stepniewska","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parepi.2026.e00477_bb0145","series-title":"National Heart Lung and Blood Institute Study Quality Assessment Tools","author":"Tool","year":"2020"},{"key":"10.1016\/j.parepi.2026.e00477_bb0150","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.parepi.2026.e00477_bb0155","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.parepi.2026.e00477_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-8-253","article-title":"Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance","volume":"8","author":"White","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.parepi.2026.e00477_bb0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.trstmh.2007.03.004","article-title":"High residual chloroquine blood levels in African children with severe malaria seeking healthcare","volume":"101","author":"Wichmann","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."}],"container-title":["Parasite Epidemiology and Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673126000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673126000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:55:20Z","timestamp":1775681720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405673126000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"alternative-id":["S2405673126000024"],"URL":"https:\/\/doi.org\/10.1016\/j.parepi.2026.e00477","relation":{},"ISSN":["2405-6731"],"issn-type":[{"value":"2405-6731","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual antimalarial drug concentrations before treatment in malaria patients in Asia and Africa: A systematic review and meta-analysis depicting its implication for drug pressure","name":"articletitle","label":"Article Title"},{"value":"Parasite Epidemiology and Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parepi.2026.e00477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of World Federation of Parasitologists.","name":"copyright","label":"Copyright"}],"article-number":"e00477"}}